Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore S Johnson

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Pediatric Blood & Cancer|September 13, 2016
Early career mentoring through the American Society of Pediatric Hematology/Oncology: Lessons learned from a pilot programSherif M Badawy, Vandy Black, Emily R Meier, et al.
Science (New York, N.Y.)|September 14, 2002
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenaseDavid H Munn, Madhav D Sharma, Jeffrey R Lee, et al.
Immunity|January 19, 2018
Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c<sup>+</sup>CD103<sup>+</sup> Monocytic Antigen-Presenting Cells in TumorsMadhav D Sharma, Paulo C Rodriguez, Brent H Koehn, et al.
Journal for Immunotherapy of Cancer|July 24, 2014
The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastomaMinghui Li, Aaron R Bolduc, Md Nasrul Hoda, et al.
Immunity|October 6, 2021
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunityMadhav D Sharma, Rafal Pacholczyk, Huidong Shi, et al.
Neuro-Oncology|September 16, 2023
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trialTheodore S Johnson, Tobey J MacDonald, Rafal Pacholczyk, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Pediatric Blood & Cancer|September 13, 2016
Early career mentoring through the American Society of Pediatric Hematology/Oncology: Lessons learned from a pilot programSherif M Badawy, Vandy Black, Emily R Meier, et al.
Science (New York, N.Y.)|September 14, 2002
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenaseDavid H Munn, Madhav D Sharma, Jeffrey R Lee, et al.
Immunity|January 19, 2018
Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c<sup>+</sup>CD103<sup>+</sup> Monocytic Antigen-Presenting Cells in TumorsMadhav D Sharma, Paulo C Rodriguez, Brent H Koehn, et al.
Journal for Immunotherapy of Cancer|July 24, 2014
The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastomaMinghui Li, Aaron R Bolduc, Md Nasrul Hoda, et al.
Immunity|October 6, 2021
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunityMadhav D Sharma, Rafal Pacholczyk, Huidong Shi, et al.
Neuro-Oncology|September 16, 2023
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trialTheodore S Johnson, Tobey J MacDonald, Rafal Pacholczyk, et al.
Pageof 2